These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6150331)

  • 1. Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine.
    Salk D; van Wezel AL; Salk J
    Lancet; 1984 Dec; 2(8415):1317-21. PubMed ID: 6150331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinology of poliomyelitis.
    Salk D; Salk J
    Vaccine; 1984 Mar; 2(1):59-74. PubMed ID: 6099644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis.
    Salk J; van Wezel AL; Stoeckel P; van Steenis G; Schlumberger M; Meyran M; Rey JL; Lapinleimu K; Böttiger M; Cohen H
    Dev Biol Stand; 1981; 47():181-98. PubMed ID: 7194827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine.
    Salk J
    Rev Infect Dis; 1984; 6 Suppl 2():S444-50. PubMed ID: 6740092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradication of poliomyelitis in the United States. III. Poliovaccines--practical considerations.
    Salk D
    Rev Infect Dis; 1980; 2(2):258-73. PubMed ID: 6994208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
    Xiao Y; Daniell H
    Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
    Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
    J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine.
    Salk D
    Rev Infect Dis; 1980; 2(2):243-57. PubMed ID: 6771867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity, safety, and antibody persistence at 3, 5, and 10 years postvaccination in adolescents randomized to booster immunization with a combined tetanus, diphtheria, 5-component acellular pertussis, and inactivated poliomyelitis vaccine administered with a hepatitis B virus vaccine concurrently or 1 month apart.
    Embree J; Law B; Voloshen T; Tomovici A
    Clin Vaccine Immunol; 2015 Mar; 22(3):282-90. PubMed ID: 25540274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity induced by inactivated poliovirus vaccine and excretion of virus.
    Chin TD
    Rev Infect Dis; 1984; 6 Suppl 2():S369-70. PubMed ID: 6330838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines.
    Faden H; Duffy L; Sun M; Shuff C
    J Infect Dis; 1993 Aug; 168(2):452-4. PubMed ID: 8335983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serological control over the state of immunity to the poliomyelitis virus in children].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN; Stepanova GS
    Vopr Virusol; 1974; (4):418-23. PubMed ID: 4373926
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of killed poliovirus vaccine in a routine immunization program in West Africa.
    Stoeckel P; Schlumberger M; Parent G; Maire B; van Wezel A; van Steenis G; Evans A; Salk D
    Rev Infect Dis; 1984; 6 Suppl 2():S463-6. PubMed ID: 6740093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.